NuCana PLC (NCNA)

US · Healthcare · Biotechnology

$1.33+2.31%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-3.1M

EPS

$-0.99

Market cap

$5.4M

P/E

0.0

Forward P/E

0.0

P/B

0.20

Book value

$6.37

EPS (TTM)

$65.62

52-week high

$7.22

52-week low

$1.21

50-day MA

$1.39

200-day MA

$2.18

Beta

2.24

Analysts rate NuCana PLC a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $104.00.

Insiders

0.00%

Institutions

2.60%

Fund	Stake
Citadel Advisors Llc	0.65%
Glass Jacobson Investment Advisors LLC	0.36%
Virtu Financial LLC	0.32%
Jane Street Group LLC	0.25%
Rhumbline Advisers	0.09%
Integrated Wealth Concepts LLC	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Acadian Asset Management LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for NuCana PLC — free to start.

Data updated 2026-09-18.